Cheung Tan-To, Wang Xiaoying, Efanov Mikhail, Liu Rong, Fuks David, Choi Gi-Hong, Syn Nicholas L, Chong Charing C, Sucandy Iswanto, Chiow Adrian K H, Marino Marco V, Gastaca Mikel, Lee Jae Hoon, Kingham T Peter, D'Hondt Mathieu, Choi Sung Hoon, Sutcliffe Robert P, Han Ho-Seong, Tang Chung Ngai, Pratschke Johann, Troisi Roberto I, Goh Brian K P
Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
Hepatobiliary Surg Nutr. 2021 Oct;10(5):587-597. doi: 10.21037/hbsn-21-327.
The application and feasibility of minimally invasive liver resection (MILR) for huge liver tumours (≥10 cm) has not been well documented.
Retrospective analysis of data on 6,617 patients who had MILR for liver tumours were gathered from 21 international centers between 2009-2019. Huge tumors and large tumors were defined as tumors with a size ≥10.0 cm and 3.0-9.9 cm based on histology, respectively. 1:1 coarsened exact-matching (CEM) and 1:2 Mahalanobis distance-matching (MDM) was performed according to clinically-selected variables. Regression discontinuity analyses were performed as an additional line of sensitivity analysis to estimate local treatment effects at the 10-cm tumor size cutoff.
Of 2,890 patients with tumours ≥3 cm, there were 205 huge tumors. After 1:1 CEM, 174 huge tumors were matched to 174 large tumors; and after 1:2 MDM, 190 huge tumours were matched to 380 large tumours. There was significantly and consistently increased intraoperative blood loss, frequency in the application of Pringle maneuver, major morbidity and postoperative stay in the huge tumour group compared to the large tumour group after both 1:1 CEM and 1:2 MDM. These findings were reinforced in RD analyses. Intraoperative blood transfusion rate and open conversion rate were significantly higher in the huge tumor group after only 1:2 MDM but not 1:1 CEM.
MILR for huge tumours can be safely performed in expert centers It is an operation with substantial complexity and high technical requirement, with worse perioperative outcomes compared to MILR for large tumors, therefore judicious patient selection is pivotal.
微创肝切除术(MILR)应用于巨大肝肿瘤(≥10 cm)的情况及可行性尚未得到充分记录。
对2009年至2019年间从21个国际中心收集的6617例行MILR治疗肝肿瘤患者的数据进行回顾性分析。根据组织学结果,巨大肿瘤和大肿瘤分别定义为直径≥10.0 cm和3.0 - 9.9 cm的肿瘤。根据临床选择的变量进行1:1精确粗匹配(CEM)和1:2马氏距离匹配(MDM)。进行回归断点分析作为额外的敏感性分析,以估计在10 cm肿瘤大小临界值处的局部治疗效果。
在2890例肿瘤≥3 cm的患者中,有205例巨大肿瘤。经过1:1 CEM后,174例巨大肿瘤与174例大肿瘤匹配;经过1:2 MDM后,190例巨大肿瘤与380例大肿瘤匹配。在1:1 CEM和1:2 MDM后,与大肿瘤组相比,巨大肿瘤组术中出血量、Pringle手法应用频率、主要并发症发生率和术后住院时间均显著且持续增加。这些结果在回归断点分析中得到强化。仅在1:2 MDM后,巨大肿瘤组的术中输血率和开放手术转换率显著高于1:1 CEM后的情况。
在专家中心,巨大肿瘤的MILR可以安全进行。这是一项具有相当复杂性和高技术要求的手术,与大肿瘤的MILR相比,围手术期结果更差,因此谨慎选择患者至关重要。